ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2017 American Transplant Congress

    Retroactive Application of a New Risk Index for Living Donor Kidney Transplantation (LKDPI) to Renal Transplants in Veracruz, Mexico.

    G. Martinez-Mier,1,2 E. Soto-Miranda,1 S. Avila-Pardo,2 L. Budar-Fernandez,1 M. Mendez-Lopez,1 P. Moreno-Ley,1 E. Aguilar-Sandoval,1 G. Coello-Torres,3 F. Diaz-Trueba.3

    1Organ Transplantation, IMSS UMAE HE 14, Veracruz, Mexico; 2Organ Transplantation, HRAEV, Veracruz, Mexico; 3Research, IMSS UMAE HE 14, Veracruz, Mexico

    Kidney Donor Profile Index (KDPI) was designed to estimate the graft loss risk in deceased donor transplants. Recently, the Epidemiology Research Group for Organ Transplantation…
  • 2017 American Transplant Congress

    Kidney Transplantation in HCV+ Recipients in a New Era of Diagnostics and Therapeutics.

    C. Traynor, S. Bumb, C. Berg, M. Ellis, J. Roberts, A. Muir, L. King, C. Brady, S. Sanoff.

    Duke University Medical Center, Durham, NC

    BackgroundHepatitis-C infected persons (HCV+) evaluated for kidney transplantation receive rigorous staging of their liver disease, often including liver biopsy. Meanwhile, studies have shown that despite…
  • 2017 American Transplant Congress

    Vimentin Regulates ß-Catenin Translocation During Epithelial to Mesenchymal Transition in Renal Fibrosis.

    R. Lopez-Soler, Z. Wang, A. Divanyan.

    Sugery, Section of Transplantation, Albany Medical Center, Albany, NY

    Introduction: Most renal transplants ultimately fail secondary to chronic allograft nephropathy (CAN). The development of Epithelial to Mesenchymal Transition (EMT) in renal tubular epithelial cells…
  • 2017 American Transplant Congress

    C-C Chemokine Receptor 5 Polymorphisms and Risk of Antibody-Mediated Rejection in Renal Transplantation.

    J. Lee,1 D. Kim,1 J. Lee,1 S.-K. Kwon,1 S. Song,1 J. Lee,1 B. Kim,2 M. Kim,1 S. Kim,1 Y. Kim,1 K. Huh.1

    1Transplantation Surgery, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea; 2Nephrology, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea

    Antibody-mediated rejection (AMR) is the leading cause of graft failure after kidney transplantation. C-C Chemokine receptor 5 (CCR5) plays an important role in immune cell…
  • 2017 American Transplant Congress

    Early Failure of Kidney Transplants in the Current Era.

    I. Helanterä, M. Lempinen.

    Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland

    A. Purpose: The short-term outcome after kidney transplantation has improved substantially, and immunological complications rarely lead to early graft loss. However, a small proportion of…
  • 2017 American Transplant Congress

    Streamlining Discharge Pathways in Kidney Transplant Recipients with Delayed Graft Function.

    E. Chan, J. Kim.

    Division of Nephrology and the Kidney Transplant Program, University of Toronto, University Health Network, Toronto, ON, Canada

    Background180 end-stage renal disease (ESRD) patients undergo kidney transplantation at the Toronto General Hospital Multi-Organ Transplant Unit yearly. 30% develop delayed graft function (DGF), defined…
  • 2017 American Transplant Congress

    Prospective Randomized Study to Evaluate the Efficacy and Safety of Rabbit Antithymocyte Globulin (rATG) 3mg/kg vs. 6mg/kg in Kidney Transplant Patients Under Steroid-Free and CNI Minimization Maintenance Immunosuppressive Regimen.

    T. Sandes-Freitas, J. Junqueira, Jr, C. Girão, M. Oliveira, R. Esmeraldo.

    Hospital Geral de Fortaleza, Fortaleza, Brazil

    Background: rATG dosed from 4.5 to 7.5mg/kg has been the standard of care in most transplant centers. Recent studies have demonstrated similar efficacy with doses…
  • 2017 American Transplant Congress

    A Single Center's Experience of Direct Acting Anti-Viral Agents in HCV Positive Patients Receiving an HCV Positive Kidney.

    N. Kapila,1 B. Zervos,2 B. Ismail,1 G. Schnickel,2 J. Rivas,2 D. Reino,2 N. Agrawal,2 A. Tzakis.2

    1Gastroenterology/Hepatology, Cleveland Clinic, Weston, FL; 2Transplant, Cleveland Clinic, Weston, FL

    Background: Nearly 8% of patients in the U.S. undergoing hemodialysis are Hepatitis C (HCV) positive. There is a survival benefit in HCV positive patients who…
  • 2017 American Transplant Congress

    Online Patient Resources for Deceased Donor and Live Donor Kidney Recipients: A Comparative Analysis of Readability.

    E. Zhou, E. Kiwanuka, W. Cioffi, P. Morrissey.

    Department of General Surgery and Division of Organ Transplantation, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, RI

    BackgroundThe Internet has extensive online resources for kidney transplantation recipients. However, it is unclear if these materials are comprehensible for kidney transplant patients. Nearly, one-half…
  • 2017 American Transplant Congress

    Protocol of the KTFT-TALK Study to Reduce Racial Disparities in Kidney Transplant Evaluation and Living Donor Kidney Transplantation.

    K. Bornemann,1 E. Croswell,1 M. Abaye,1 C. Bryce,1 J. Chang,1,2 D. Good,3 C. Freehling Heiles,3 M. Dew,1 L. Boulware,4 A. Tevar,1,3 L. Myaskovsky.1,2

    1University of Pittsburgh, Pittsburgh; 2VA Pittsburgh Healthcare System, Pittsburgh; 3University of Pittsburgh Medical Center, Pittsburgh; 4Duke University School of Medicine, Durham

    Living donor kidney transplantation (LDKT) is the optimal treatment for end-stage kidney disease (ESKD). But, the evaluation process for a kidney transplant is complex, time…
  • « Previous Page
  • 1
  • …
  • 383
  • 384
  • 385
  • 386
  • 387
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences